The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 158, 162-166
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Is it Time to Change Radiotherapy: The Dawning of Chronoradiotherapy?Clinical Oncology, 2019
- Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer PatientsClinical Oncology, 2019
- Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysisThe Lancet Oncology, 2017
- Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manualCA: A Cancer Journal for Clinicians, 2017
- Research on radiotherapy at different times of the day for inoperable cervical cancerInt. Journal of Clinical Pharmacology and Therapeutics, 2016
- Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resectionJournal of Radiation Research, 2014
- Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancerJournal of Clinical Epidemiology, 2011
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialThe Lancet Oncology, 2011
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology GroupThe Lancet Oncology, 2007